Tag : JampJs

Latest News

UCB psoriasis drug beats J&J’s second top-selling product in Phase III study

Newsemia
Results of the BE VIVID study showed that UCB’s bimekizumab showed a statistically significant improvement in skin clearance compared with J&J’s Stelara and placebo. Source...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy